Spanish government sets stricter tenders agenda
This article was originally published in Clinica
The Spanish government has been forced to stop direct tender contracts following a ruling by the European Commission. All public tenders for medical equipment in Spain must now appear in official publications, says the Spanish government's new tenders law, which will come into force on June 8th. It declares that only tenders below Pta 2 million ($16,000) will not require public announcement and can be awarded to suppliers directly. The law, published in the official journal of May 19th, confirms that tenders for medical supplies which exceed Pta 102,248,281 ($815,000) must also be published in the Official Journal of the European Communities.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.